Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia

The clinically ideal time point and optimal approach for the assessment of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) are still inconclusive. We investigated the clinical value of multiparameter flow cytometry-based MRD (MFC MRD) after induction (n = 492) and two...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-Jia, Cheng, Wen-Yan, Lin, Xiao-Jing, Wang, Shi-Yang, Jiang, Tian-Yi, Ma, Ting-Ting, Zhu, Yong-Mei, Shen, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173083/
https://www.ncbi.nlm.nih.gov/pubmed/34094982
http://dx.doi.org/10.3389/fonc.2021.677833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173083/
https://www.ncbi.nlm.nih.gov/pubmed/34094982
http://dx.doi.org/10.3389/fonc.2021.677833

Ejemplares similares